About this trial
Around 15,000 ENT cancers are diagnosed each year in France. The majority of these cancers will at one time or another require an Endoscopy of the Pharynx, Larynx and Esophagus (Endo-PLE or suspension laryngoscopy). Endoscopies of the Otorhinolaryngeal (ENT) sphere are common procedures. They consist of inserting a rigid laryngoscope through the mouth, allowing full exposure of the laryngeal sphere. They are performed in most cases as part of a swelling assessment, following CT scans, or following the discovery of a mass upon palpation of the patient. Unfortunately, these are aggressive cancers that subsequently require major surgery and additional treatment by radio or chemotherapy. This examination can also be performed on patients suffering from swallowing disorders, following the appearance of polyps, and this time not requiring an adjuvant to surgery but their removal. For all patients, these endo-PLE are performed in the operating room and require general anesthesia. This surgical procedure is now performed by performing two laryngoscopies. The first is used to maintain good pulmonary oxygenation by introducing an oxygen cannula, the second constitutes the surgical procedure itself. The oxygen cannula is placed through the nasal cavity, directly up to the entrance of the vocal cords. This procedure is not without risk both for the patient (risk of dental breakage and bleeding during laryngoscopy) but also for the surgeon, because the cannula itself can obstruct his vision. It would be possible to do without one of them by setting up high-flow oxygen therapy (HFOT). This device has been widely deployed in continuous care and intensive care units, but is not yet the subject of much research in surgical units. The HFOT consists of oxygen cannulae delivering a mixture of gases at a high flow rate ranging from 20 to 70 liters per minute. The investigator want to evaluate through this study, the feasibility and effectiveness of setting up HFOT during procedures. The evaluation of this benefit compared to the standard method will be done using several elements including the collection of continuous saturation and blood analysis of capillary samples pre-, per- and post-operatively.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient aged 18 or over.
Not requiring oxygen.
About to undergo exclusive Endoscopy of the pharynx, larynx and oesophagus surgery.
Score de l'American Society of Anesthesiology between 1 and 4
Disqualifiers
Endoscopy of the pharynx, larynx and oesophagus surgery combined with another procedure
Severe or morbid obesity (BMI ≥ 35 kg/m²)
Patients with stage IV chronic obstructive pulmonary disease
Allergy to one of the drugs used in anaesthesia, remifentanil and/or propofol and/or lidocaine.
Trial design
Parallel
Treatments tested in this trial
Laryngoscopy
Procedure/SurgeryIntroduction of the laryngoscope to maintain spontaneous ventilation in order to observe, in real conditions, the evolution and movements of the otorhinolaryngology sphere.
High-flow oxygen therapy
Procedure/SurgeryIntroduction of High-flow oxygen therapy to maintain spontaneous ventilation in order to observe, in real conditions, the evolution and movements of the otorhinolaryngology sphere.
Treatment groups
Trial outcomes
Primary outcomes
The presence of oxygen desaturation ≤ 85% (Pulse Oxygen Saturation ) of the patient ≤ 85%.
during the surgery
Secondary outcomes
Level of oxygenation
Oxygenation is assessed by arterial blood gas sample
Presence of bleeding from mouth and pharynx and rupture of teeth related to laryngoscopy
On leaving the Post Interventional Monitoring Room
Patient pain assessed
pain is evaluated using a 100 mm visual-analogue scale, from 0, i.e "no pain", to 100 mm, i.e. "maximal imaginable pain"
The surgeon's comfort during the operation
comfort is evaluated using a 100 mm visual-analogue scale, from 0, i.e "no discomfort", to 100 mm, i.e. "maximal imaginable discomfort"
Sponsors and contacts
Click on the lead sponsor to view all of their trials.